Schedule a 15-minute appointment with a client advisor today. Start

FAQS

  • I would be interested to know who the patient population would be for SenSights.AI devices? Will it be COVID patients or Non-COVID patients? Or will it be in-patients, out-patients, discharged patients? 
  • Our initial target segment is primarily the older adult population that is living at home (aging in place) and receiving some form of Homecare services. 

    The goal of SenSights.AI company and our SenSights.AI platform is to:

    1. Keep them at home and not move to senior living institutions for as long as feasible;
    2. reduce hospital readmissions, and;
    3. provide real-time insights that can be acted upon.

    Furthermore, SenSights.AI can explore other patient populations like caregivers that are of interest to the hospital like COVID-19 users or general or specific patients like orthopedic, heart and stroke patients that can be added relatively easily.

  • What will be the disease or outcome for risk stratification of low/medium/high risk?
  • Our initial focus was on “wandering” in early-stage Dementia patients but we are looking to extend it to “fall-detection” and also introduce step-wise Risk Propensity modeling for the main chronic diseases (Diabetes, CHF, COPD, Hypertension, etc.)

  • Who would be medically responsible for the results of the monitoring devices - e.g. if the oxygen saturation were to decrease, who would be the healthcare provider that gets notified? Also, what is done about it?  
  • As per our current model, it is the Homecare partner or a doctor at a Clinic. However, this requires deeper discussion with the respective health institution and is dependent upon what resources they have and what services they are interested in covering.

     

    We can also provide triage services e (CHC or FONEMED) and non healthcare 24/7 providers (eg., COPSMONITORING) to provide cover at a cost.

  • Medical-legally, if a hospital/physician group is giving out wearables, they would be liable and responsible for acting on the information sent back. Or would SenSights.AI be responsible for this?
  • SenSights.AI is the tech vendor, and we would rely on the partner Hospital or Doctor to provide the medical response. However, the system will generate alerts and insights to support the response.

     

    There are many variables involved along the information spectrum and our reason for doing such pilots is to understand roles and responsibilities

  • Is the SenSights.AI product direct-to-consumer like Apple Watch, FitBit etc?  
  • No, the SenSights.AI product is not direct-to-consumer but is a business model, B2B2C and we also work with potential existing technology vendors of healthcare to provide a partnership model.

  • How do patients get recruited?  If recruitment of patients occurs in a hospital, I would have to get ethics/hospital approvals which could take some time (even if not integrating with hospital system).
  • As per our current model, it is the Homecare partner or a doctor at a Clinic. However, this requires deeper discussion with the respective health institution and is dependent upon what resources they have and what services they are interested in covering.

     

    We can also provide triage services e (CHC or FONEMED) and non healthcare 24/7 providers (eg., COPSMONITORING) to provide cover at a cost.

  • What kind of questions is SenSights.AI interested in from a clinical perspective? From a computer science/data perspective?  
  • As the platform vendor, SenSights.AI is keen to get feedback that will:

    1. help us improve the user experience of interfacing with the platform (screens, features, etc.);
    2. help us understand which use-cases are most requested by the users;
    3. allow us to define the specific program
  • Also, how is SenSights.AI different from say apple storing wearable data?
  • Apple and others (Samsung, Fitbit, Halo etc.) are B2C products and SenSights.AI works with all of these, and consolidates the data into a Health Intelligence Platform, that provides the integration into the respective Medical partner’s existing ecosystem.